Jaguar Health/$JAGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Jaguar Health
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Ticker
$JAGX
Sector
Primary listing
Employees
49
Headquarters
Website
Jaguar Health Metrics
BasicAdvanced
$4.5M
-
-$93.54
0.70
-
Price and volume
Market cap
$4.5M
Beta
0.7
52-week high
$15.48
52-week low
$1.93
Average daily volume
90K
Financial strength
Current ratio
1.079
Quick ratio
0.251
Long term debt to equity
586.033
Total debt to equity
1,156.44
Profitability
EBITDA (TTM)
-30.159
Gross margin (TTM)
82.34%
Net profit margin (TTM)
-343.92%
Operating margin (TTM)
-277.33%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-37.48%
Return on equity (TTM)
-459.52%
Valuation
Price to revenue (TTM)
0.086
Price to book
0.89
Price to tangible book (TTM)
-0.1
Price to free cash flow (TTM)
-0.033
Free cash flow yield (TTM)
-2,994.91%
Free cash flow per share (TTM)
-70.361
Growth
Revenue change (TTM)
13.93%
Earnings per share change (TTM)
-89.98%
3-year revenue growth (CAGR)
26.41%
Jaguar Health News
AllArticlesVideos
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
Accesswire·1 day ago
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Accesswire·3 days ago
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Jaguar Health stock?
Jaguar Health (JAGX) has a market cap of $4.5M as of August 15, 2025.
What is the P/E ratio for Jaguar Health stock?
The price to earnings (P/E) ratio for Jaguar Health (JAGX) stock is 0 as of August 15, 2025.
Does Jaguar Health stock pay dividends?
No, Jaguar Health (JAGX) stock does not pay dividends to its shareholders as of August 15, 2025.
When is the next Jaguar Health dividend payment date?
Jaguar Health (JAGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Jaguar Health?
Jaguar Health (JAGX) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.